Depressed Metabolism

It’s difficult to follow up a best-selling book about the cultural history of the penis, but David M. Friedman has a knack for engaging readers in topics that others find difficult to broach. This time he tackles the touchy subject of death by relating the intertwined biographies of Charles Lindbergh and Alexis Carrel in [...]

Unless you are a long-time cryonicist or a surgeon, you may not have heard of BioTime before. This company, recently profiled for its innovative stem cell research in Life Extension Magazine, is best known for producing the blood-volume expander Hextend, which was initially developed by Trans Time, an early cryonics company performing ultra-profound hypothermia research. [...]

Life Extension Foundation (LEF) unveiled a new blood test in an article in this month’s Life Extension Magazine (November 2008). Unlike cholesterol testing, which simply gives a measurement of high-density (HDL) and low-density (LDL) lipoprotein levels and provides little information about acute risk of stroke or heart attack, the PLAC® blood test “can accurately identify [...]

On August 23, Chana and Aschwin de Wolf drafted a blog entry on the phenomenon of partners who are hostile to cryonics. We sent our draft for review to a number of high profile cryonicists and received a message from Mike Darwin telling us that he still had an unpublished article on this topic. Because [...]

In ‘Who is Against Evolution?’, David Friedman discusses the phenomenon that most people who are against teaching creationism tend to avoid and discourage discussing the human implications of evolution themselves:

People who say they are against teaching the theory of evolution are very likely to be Christian fundamentalists. But people who are against taking seriously the [...]

It is well established that investors with a diversified portfolio of index funds can do just as well (if not better) than “professional fund managers.” Now comes a new study that shows that consumers predict inflation as accurately as professional economists.

Thomas and Alan Grant of Baker University in Kansas analyzed surveys of U.S. and Australian [...]

The blog Soft Machines writes about a new opinion piece in the Financial Times by David Shaywitz and Nassim Nicholas Taleb on biomedical science and drug discovery. The molecular revolution in biology was supposed to substitute rational design of drugs for trial and error and handwaving. So why do pharmaceutical companies have so little to [...]

One problem in assessing the merits of taking a specific dietary supplement (ranging from vitamins to  exotic multi-ingredient compounds) is widespread selection bias in the documentation that is supposed to support the use of the supplement in question.  The sheer number of scientific studies combined with variation in research methodologies virtually guarantees that for every [...]

In an effort to determine why so many cytoprotective treatments for stroke that are shown to be promising in laboratory animal experiments ultimately fail in human clinical trials, DeBow et al. performed an analysis of cytoprotection studies published in several leading journals. While noting that limitations in preclinical assessments also contribute to the premature advancement [...]